Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dietary Treatment of Glucose Transporter Type 1 Deficiency (G1D)

NCT03181399 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.

NCT NCT03181399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03181399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dietary Treatment of Glucose Transporter Type 1 Deficiency (G1D)
Lead sponsor
University of Texas Southwestern Medical Center
Phase
Phase 2
Overall status
Completed
Start date
April 18, 2018
Completion date
September 10, 2023
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, glucose metabolism disorders, glucose transport defect, glucose transporter protein type 1 deficiency syndrome, glucose transporter type 1 deficiency syndrome, glut1 deficiency syndrome 1, autosomal recessive, glut1ds1